Silicon process enhancement to enable 3D chest-imaging at the Point-of-Care
Silicon process enhancement to enable 3D chest-imaging at the Point-of-Care
批准号:
10000864
负责人:
金额:
$126.16万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --
中文摘要
**主要目标:**开发一种低剂量,低成本的系统,可用于NHS在整个医院的护理点提供3D胸部成像(具有部署到初级保健的能力)。**视力:** 2D成像是NHS诊断的主力。根据英国国家医疗服务体系的统计数据,“截至2018年3月,英国报告了4270万例影像学检查。”...这些测试中最常见的是胸部x光检查,2017/18年度通过所有源设置请求了830万次测试(增加了1.0个)% from 2016/17)._ _This was also the most common test requested by GPs (2.2 million)."_ (NHS Diagnostic Imaging Dataset Annual Statistical Release 2017/18)In the NHS 3D imaging is growing faster in clinical practice than 2D due to the greater diagnostic certainty that results from 3D imaging. However, currently the patient must travel to 3D imaging which creates cost and (in some cases) risk.**Focus:** The focus of this innovation would be to replace 2D X-ray with 3D X-ray. The specific focus would look to replace 2D Chest X-ray ('CXR') which alone represents 36% of UK X-rays and 19% of UK diagnostic imaging. 2D imaging already travels to the patient in the ICU, pulmonary ward and Accident & Emergency ('A&E').Chest X-rays ('CXR') are the primary imaging modality used in the intensive care unit (ICU), given its portability, rapid image acquisition, and immediate bedside return of information on the preview screen. We aim to provide an alternative 3D chest imaging modality, at the point-of-care, with enhanced sensitivity, with roughly equivalent dose as 2D X-ray, and at a similar price.**Innovation:** The key clinical innovation is "_3D-at-the-bedside_". The technological innovation encompasses novel hardware, elements of the software and reconstruction approach and various technological approaches for specific use cases. This project is focused on increasing the capability of the core technology to deliver bedside 3D chest imaging.**Collaboration:** The University of Edinburgh (the Scottish Microelectronics Centre \['SMC'\]) will focus on enhanced silicon manufacturing processes to increase the output, decrease variation in output, and increase yield.
英文摘要
**Key Objective:** To develop a low-dose, low-cost system that can be used by the NHS to provide 3D chest imaging at the point-of-care throughout the hospital (with the capability to deploy into Primary Care).**Vision:** 2D imaging is the workhorse of the NHS diagnostics. According to NHS statistics, "_42.7 million imaging tests were reported in England in the year to March 2018." ..._"_The most common of these tests was Chest X-ray, with 8.3 million tests being requested through all source settings in 2017/18 (up 1.0% from 2016/17)._ _This was also the most common test requested by GPs (2.2 million)."_ (NHS Diagnostic Imaging Dataset Annual Statistical Release 2017/18)In the NHS 3D imaging is growing faster in clinical practice than 2D due to the greater diagnostic certainty that results from 3D imaging. However, currently the patient must travel to 3D imaging which creates cost and (in some cases) risk.**Focus:** The focus of this innovation would be to replace 2D X-ray with 3D X-ray. The specific focus would look to replace 2D Chest X-ray ('CXR') which alone represents 36% of UK X-rays and 19% of UK diagnostic imaging. 2D imaging already travels to the patient in the ICU, pulmonary ward and Accident & Emergency ('A&E').Chest X-rays ('CXR') are the primary imaging modality used in the intensive care unit (ICU), given its portability, rapid image acquisition, and immediate bedside return of information on the preview screen. We aim to provide an alternative 3D chest imaging modality, at the point-of-care, with enhanced sensitivity, with roughly equivalent dose as 2D X-ray, and at a similar price.**Innovation:** The key clinical innovation is "_3D-at-the-bedside_". The technological innovation encompasses novel hardware, elements of the software and reconstruction approach and various technological approaches for specific use cases. This project is focused on increasing the capability of the core technology to deliver bedside 3D chest imaging.**Collaboration:** The University of Edinburgh (the Scottish Microelectronics Centre \['SMC'\]) will focus on enhanced silicon manufacturing processes to increase the output, decrease variation in output, and increase yield.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Neural Process模型的多样化高保真技术研究
-
批准号:62306326
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王琦
-
依托单位:
磁转动超新星爆发中weak r-process的关键核反应
-
批准号:12375145
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:金仕纶
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
富营养化藻分段式水热液化过程营养元素N迁移及低N成油机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:黄艳琴
-
依托单位:
多臂Bandit process中的Bayes非参数方法
-
批准号:71771089
-
项目类别:面上项目
-
资助金额:48.0万元
-
批准年份:2017
-
负责人:吴贤毅
-
依托单位:
基于非参数统计模型的遥感图像理解与典型目标识别研究
-
批准号:61071137
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2010
-
负责人:姜志国
-
依托单位:
OFDMA和SC-FDMA系统上行链路初同步方法研究
-
批准号:60902028
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:傅晓宇
-
依托单位: